Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Fengmin Zhao, John Peipert, Ju-Whei Lee, Fangxin Hong, Edward Ip, Ilana F Gareen, Nathaniel O'Connell, Ruth Carlos, Ingrid A. Mayer, Kathy Miller, Ann H. Partridge, Tait D. Shanafelt, A. Keith Stewart, Ahmad A. Tarhini, Mary L Thomas, Matthias Weiss, Joseph A. Sparano, David Cella, Robert James Gray, Lynne I. Wagner
Institutions: Dana-Farber Cancer Institute, Northwestern University, Harvard University, Wake Forest University Health Sciences, Wake Forest University, Brown University, U-M Rogel Cancer Center, Vanderbilt University, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Mayo Clinic, Mayo Clinic in Arizona, Moffitt Cancer Center, VA Palo Alto Health Care System, ThedaCare, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3029407015